Your browser doesn't support javascript.
loading
Structural basis of synthetic agonist activation of the nuclear receptor REV-ERB.
Murray, Meghan H; Valfort, Aurore Cecile; Koelblen, Thomas; Ronin, Céline; Ciesielski, Fabrice; Chatterjee, Arindam; Veerakanellore, Giri Babu; Elgendy, Bahaa; Walker, John K; Hegazy, Lamees; Burris, Thomas P.
Afiliação
  • Murray MH; Department of Pharmacology and Physiology, Saint Louis University School of Medicine, St. Louis, MO, 63104, USA.
  • Valfort AC; Center for Clinical Pharmacology, Washington University School of Medicine, University of Health Sciences & Pharmacy, St. Louis, MO, 63110, USA.
  • Koelblen T; University of Florida Genetics Institute, Gainesville, FL, 32610, USA.
  • Ronin C; University of Florida Genetics Institute, Gainesville, FL, 32610, USA.
  • Ciesielski F; NovAliX SAS, Strasbourg, France.
  • Chatterjee A; NovAliX SAS, Strasbourg, France.
  • Veerakanellore GB; Department of Pharmacology and Physiology, Saint Louis University School of Medicine, St. Louis, MO, 63104, USA.
  • Elgendy B; Center for Clinical Pharmacology, Washington University School of Medicine, University of Health Sciences & Pharmacy, St. Louis, MO, 63110, USA.
  • Walker JK; Department of Pharmaceutical and Administrative Sciences, University of Health Sciences & Pharmacy, St. Louis, MO, 63110, USA.
  • Hegazy L; Center for Clinical Pharmacology, Washington University School of Medicine, University of Health Sciences & Pharmacy, St. Louis, MO, 63110, USA.
  • Burris TP; Department of Pharmaceutical and Administrative Sciences, University of Health Sciences & Pharmacy, St. Louis, MO, 63110, USA.
Nat Commun ; 13(1): 7131, 2022 11 21.
Article em En | MEDLINE | ID: mdl-36414641
ABSTRACT
The nuclear receptor REV-ERB plays an important role in a range of physiological processes. REV-ERB behaves as a ligand-dependent transcriptional repressor and heme has been identified as a physiological agonist. Our current understanding of how ligands bind to and regulate transcriptional repression by REV-ERB is based on the structure of heme bound to REV-ERB. However, porphyrin (heme) analogues have been avoided as a source of synthetic agonists due to the wide range of heme binding proteins and potential pleotropic effects. How non-porphyrin synthetic agonists bind to and regulate REV-ERB has not yet been defined. Here, we characterize a high affinity synthetic REV-ERB agonist, STL1267, and describe its mechanism of binding to REV-ERB as well as the method by which it recruits transcriptional corepressor both of which are unique and distinct from that of heme-bound REV-ERB.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Porfirinas / Membro 1 do Grupo D da Subfamília 1 de Receptores Nucleares Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Porfirinas / Membro 1 do Grupo D da Subfamília 1 de Receptores Nucleares Idioma: En Ano de publicação: 2022 Tipo de documento: Article